Overview
- 9 FDA inspections are on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2026-03-02.
At a glance
Inspections
9
Form 483s
1
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 27 Feb 2026 – 2 Mar 2026 | Biologics | Clean | |
| 25 Apr 2022 – 2 May 2022 | Biologics | 483 | View 483 → |
| 10 Jul 2018 | Biologics | Clean | |
| 11 Sep 2015 | Biologics | Clean | |
| 3 Mar 2014 | Biologics | Clean | |
| 10 Nov 2011 | Not recorded | Clean | |
| 16 Nov 2009 | Not recorded | Clean | |
| 15 Oct 2004 | Not recorded | Clean | |
| 13 Dec 2002 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
2 May 2022
21 CFR 606.100(b)
Establish, maintain and follow manufacturing SOPs
Cited by Shelley H Beausoleil, Richard L Bartlett
2 May 2022
21 CFR 606.100(b)
Establish, maintain and follow manufacturing SOPs
Cited by Shelley H Beausoleil, Richard L Bartlett
2 May 2022
21 CFR 606.65(e)
Following manufacturer's instructions
Cited by Shelley H Beausoleil, Richard L Bartlett
2 May 2022
21 CFR 606.65(e)
Following manufacturer's instructions
Cited by Shelley H Beausoleil, Richard L Bartlett
2 May 2022
21 CFR 606.100(b)
Establish, maintain and follow manufacturing SOPs
Cited by Shelley H Beausoleil, Richard L Bartlett
Investigators
FDA investigators tied to this site in the record.
Shelley H Beausoleil7 insp.
Richard L Bartlett1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 606.100(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 606.65(e) | Cited across public-safe Form 483 observations | 3x |
Full site report
Get the verbatim findings behind Vitalant's 1 Form 483
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat